Metraipolis › archive › dc_b6fef5073d72
Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol — Europe PMC PMID:41481895
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41481895
- DOI
- 10.1097/hc9.0000000000000839
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-01T09:34:24.687Z
- SHA-256 of the archived text
dbe2fb288fd71abfd1724253e865a2a1feda75acfbfdd30040f61e84637ac755- Stable URL of this page
https://metraipolis.com/documento/dc_b6fef5073d72
How to cite
Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol — Europe PMC PMID:41481895 — Europe PMC (en), https://europepmc.org/article/MED/41481895 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b6fef5073d72 (Metraipolis archive dc_b6fef5073d72, sha256 dbe2fb288fd71abfd1724253e865a2a1feda75acfbfdd30040f61e84637ac755)
BibTeX
@misc{dcb6fef5073d72,
title = {Abbreviated gadoxetic acid-enhanced MRI versus ultrasonography for HCC surveillance in high-risk patients: A randomized trial protocol — Europe PMC PMID:41481895},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41481895},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b6fef5073d72; sha256 dbe2fb288fd71abfd1724253e865a2a1feda75acfbfdd30040f61e84637ac755},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41481895. Agents can read the archived copy with the MCP tool read_document.